Printer Friendly
The Free Library
21,440,732 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Sheri L. Rowen, M.D., Mercy Medical Center, Baltimore, Oct. 11 (CDRH).

An investigator from FDA's Baltimore office conducted the May 12 June 2 audit to determine if Rowen's activities as a clinical investigator A clinical investigator involved in a clinical trial is responsible for ensuring that an investigation is conducted according to the signed investigator statement, the investigational plan, and applicable regulations; for protecting the rights, safety, and welfare of subjects under , for an unnamed device, complied with applicable regulations. Several violations were found, including that Rowen row·en  
n. New England
A second crop, as of hay, in a season.



[Middle English rowein, from Anglo-Norman rewain, variant of Old French regain : re-, re- +
 failed to provide adequate informed consent forms JCF JCF Jewish Community Federation
JCF JESSI (Joint European Submicron Silicon Initiative) Common Framework
JCF Joint Contingency Force
JCF Jacques Chahine Finance
JCF Jamaica Chess Federation
JCF Jewelers Charity Fund for Children
) and failed to follow the study protocol as a part of the investigational plan. Specifically, 23 out of 41 study subjects were seen for four- and five-year, postoperative follow-up exams without signing an amended approved ICE

Rowen also failed to submit complete, accurate and timely reports in that the sponsor notified Rowen in a letter of the official closure of the investigation, but the final report was not sent to the sponsor and IRB IRB

See: Industrial Revenue Bond
 until well past the official closure date.

FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 reviewed Rowen's response dated June 30 and advised that additional written documentation of the specific steps taken to correct the violations and prevent the recurrence of similar violations in current and future studies would be required. BiMO; Doc. 13667W
COPYRIGHT 2005 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:MEDICAL DEVICES
Publication:Warning Letter Bulletin
Date:Nov 1, 2005
Words:166
Previous Article:Ram Precision Industries, Inc., Centreville, OH, Oct. 17 (Cincinnati).
Next Article:Debra E. Weese-Mayer, M.D., Rush University Medical Center, Chicago, Oct. 14 (CDRH).
Topics:



Related Articles
CDRH-BIMO NOV ("UNTITLED') LETTERS
RADIOLOGICALS/MAMMOGRAPHY.
Names in the News.
CDRH BiMo untitled letters.
Baltimore blood bank cited in 5-item 483 for Part 11 flaws, inadequate process control procedures.
BiMo inspection FOIA log.
Lack of IRB approval before recruiting subjects for study cited in 5-item 483.
483/EIR update.
BioResearch Compliance Report inspection UPDATE.
IT infrastructure fills the bill: medical center switches to single directory approach to manage its network.

Terms of use | Copyright © 2013 Farlex, Inc. | Feedback | For webmasters | Submit articles